Goldman Sachs’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$36.6M Buy
74,500
+22,300
+43% +$12.1M ﹤0.01% 1835
2025
Q4
$30.2M Buy
52,200
+51,700
+10,340% +$29.2M ﹤0.01% 1967
2025
Q3
$243K Sell
500
-1,600
-76% -$745K ﹤0.01% 5869
2025
Q2
$851K Sell
2,100
-400
-16% -$167K ﹤0.01% 4813
2025
Q1
$1.24M Sell
2,500
-2,000
-44% -$1.08M ﹤0.01% 4524
2024
Q4
$2.34M Sell
4,500
-10,000
-69% -$5.5M ﹤0.01% 4149
2024
Q3
$8.97M Buy
14,500
+8,500
+142% +$5.03M ﹤0.01% 2832
2024
Q2
$3.32M Sell
6,000
-6,400
-52% -$3.67M ﹤0.01% 3531
2024
Q1
$7.21M Sell
12,400
-20,900
-63% -$11.7M ﹤0.01% 2769
2023
Q4
$17.7M Buy
33,300
+10,400
+45% +$5.03M ﹤0.01% 2015
2023
Q3
$11.6M Buy
22,900
+12,000
+110% +$6.39M ﹤0.01% 2266
2023
Q2
$5.69M Sell
10,900
-19,900
-65% -$10.7M ﹤0.01% 2995
2023
Q1
$17.8M Sell
30,800
-24,300
-44% -$13.7M ﹤0.01% 1915
2022
Q4
$30.3M Buy
55,100
+4,300
+8% +$2.28M 0.01% 1583
2022
Q3
$25.8M Buy
50,800
+14,600
+40% +$8.17M 0.01% 1640
2022
Q2
$19.7M Buy
36,200
+7,900
+28% +$4.35M ﹤0.01% 1908
2022
Q1
$16.7M Sell
28,300
-8,900
-24% -$5.11M ﹤0.01% 2202
2021
Q4
$24.8M Buy
37,200
+13,300
+56% +$8.3M ﹤0.01% 1939
2021
Q3
$13.7M Buy
23,900
+7,200
+43% +$3.95M ﹤0.01% 2418
2021
Q2
$8.43M Buy
16,700
+1,100
+7% +$519K ﹤0.01% 2859
2021
Q1
$7.12M Sell
15,600
-36,600
-70% -$17.5M ﹤0.01% 2838
2020
Q4
$24.3M Buy
52,200
+37,300
+250% +$17.5M 0.01% 1699
2020
Q3
$6.58M Buy
14,900
+11,600
+352% +$4.79M ﹤0.01% 2688
2020
Q2
$1.2M Buy
+3,300
New +$1.11M ﹤0.01% 3833
2019
Q3
Sell
-12,600
Closed -$3.7M 5379
2019
Q2
$3.7M Sell
12,600
-3,900
-24% -$1.07M ﹤0.01% 3074
2019
Q1
$4.52M Sell
16,500
-55,200
-77% -$13.7M ﹤0.01% 3051
2018
Q4
$16M Sell
71,700
-18,600
-21% -$4.36M 0.01% 1976
2018
Q3
$22M Buy
90,300
+21,100
+30% +$4.85M 0.01% 1841
2018
Q2
$14.3M Buy
69,200
+1,100
+2% +$233K ﹤0.01% 2141
2018
Q1
$14.1M Buy
68,100
+34,900
+105% +$7.33M ﹤0.01% 2091
2017
Q4
$6.3M Sell
33,200
-1,700
-5% -$326K ﹤0.01% 2806
2017
Q3
$6.6M Buy
34,900
+9,400
+37% +$1.7M ﹤0.01% 2914
2017
Q2
$4.45M Sell
25,500
-300
-1% -$50.4K ﹤0.01% 3154
2017
Q1
$3.96M Sell
25,800
-11,800
-31% -$1.8M ﹤0.01% 3134
2016
Q4
$5.3M Sell
37,600
-2,400
-6% -$354K ﹤0.01% 3000
2016
Q3
$6.36M Sell
40,000
-258,900
-87% -$39.9M ﹤0.01% 2841
2016
Q2
$44.2M Sell
298,900
-85,700
-22% -$12.6M 0.01% 1206
2016
Q1
$54.5M Buy
384,600
+357,400
+1,314% +$47.9M 0.02% 1028
2015
Q4
$3.86M Buy
27,200
+1,600
+6% +$213K ﹤0.01% 3077
2015
Q3
$3.13M Sell
25,600
-42,100
-62% -$5.48M ﹤0.01% 3338
2015
Q2
$8.79M Buy
67,700
+15,400
+29% +$2.01M ﹤0.01% 2446
2015
Q1
$7.03M Sell
52,300
-4,000
-7% -$516K ﹤0.01% 2585
2014
Q4
$7.05M Buy
56,300
+2,600
+5% +$316K ﹤0.01% 2661
2014
Q3
$6.54M Sell
53,700
-4,300
-7% -$523K ﹤0.01% 2757
2014
Q2
$6.84M Sell
58,000
-9,500
-14% -$1.12M ﹤0.01% 2713
2014
Q1
$8.12M Sell
67,500
-38,700
-36% -$4.6M ﹤0.01% 2547
2013
Q4
$11.8M Buy
106,200
+51,400
+94% +$5.11M ﹤0.01% 2218
2013
Q3
$5.05M Sell
54,800
-13,900
-20% -$1.26M ﹤0.01% 2903
2013
Q2
$5.81M Buy
+68,700
New +$5.72M ﹤0.01% 2593

Other funds holding TMO

Goldman Sachs's TMO Position: Q1 2026 in Review

Goldman Sachs increased its Thermo Fisher Scientific (TMO) stake by 2.9% in Q1 2026, buying an estimated $49M and bringing the position to 3,157,226 shares worth $1.55B. The position accounts for 0.18% of the portfolio, ranked #91.

Goldman Sachs first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.78B in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Goldman Sachs held 3,157,226 shares of Thermo Fisher Scientific worth $1.55B as of Q1 2026.
  • Goldman Sachs bought 90,342 Thermo Fisher Scientific shares in Q1 2026, an estimated $49M.
  • Thermo Fisher Scientific made up 0.18% of Goldman Sachs's portfolio in Q1 2026, its #91 holding.
  • Goldman Sachs first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Thermo Fisher Scientific position peaked at $1.78B in Q4 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.